Agios Pharma names Ian Clark to board of directors
Most recently, Mr. Clark served as the chief executive officer and member of the board of directors at Genentech.
Prior to his role of chief executive officer, Mr. Clark held executive management roles at Genentech, including head of global product strategy, chief marketing officer, senior vice president, general manager of biooncology and executive vice president for commercial operations.
Prior to these roles, Mr. Clark served as general manager, Novartis Canada and chief operating officer for Novartis U.K.
He served in positions of increasing strategic importance in sales, marketing and business development at Ivax Pharma and Sanofi in the United Kingdom, France and Eastern Europe.
Mr. Clark started his career at Searle (a subsidiary of Monsanto Corporation), holding positions in both sales and marketing.
Mr. Clark serves as a member of the Economic Advisory Council at the Federal Reserve Bank of San Francisco, a member of the Executive Council at TechNet, a member of the Executive Committee at the Biotechnology Innovation Organization and an independent director of TerraVia Holdings.
Mr. Clark received his B.S. in biological sciences from Southampton University in the United Kingdom. ■
LATEST MOVES FROM Massachusetts
- Haemonetics Corporation appoints Robert E. Abernathy to board
- Tetraphase Pharma appoints Kamalam Unninayar as CFO
- Boston Biomedical appoints Edgar Braendle as vice president
- Analogic Corporation appoints Joseph Whitters to board
- Eleven Biotherapeutics appoints Richard F. Fitzgerald as interim CFO
More inside POST